{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T05:53:43Z","timestamp":1776664423779,"version":"3.51.2"},"reference-count":11,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T00:00:00Z","timestamp":1776643200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>We report a case of a 67-year-old man with rheumatoid arthritis (RA) presenting with symmetrical annular plaques confined to the face. Histopathology demonstrated dense dermal eosinophilia without flame figures, consistent with eosinophilic annular erythema (EAE). Unlike the typical truncal distribution, lesions were limited to the face, a presentation reported in approximately 3% of cases. The patient was successfully treated with tofacitinib, a Janus kinase (JAK) inhibitor. This report illustrates a rare facial variant of EAE and supports the efficacy of JAK inhibition in patients with concurrent RA.<\/jats:p>","DOI":"10.3389\/fimmu.2026.1792217","type":"journal-article","created":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T05:24:40Z","timestamp":1776662680000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Case Report: Facial-limited eosinophilic annular erythema in a patient with rheumatoid arthritis: successful treatment with tofacitinib"],"prefix":"10.3389","volume":"17","author":[{"given":"Man-Ning","family":"Wu","sequence":"first","affiliation":[{"name":"Beijing University of Chinese Medicine","place":["Beijing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Dermatology, China-Japan Friendship Hospital, National Center for Integrative Medicine","place":["Beijing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan-Ping","family":"Bai","sequence":"additional","affiliation":[{"name":"Department of Dermatology, China-Japan Friendship Hospital, National Center for Integrative Medicine","place":["Beijing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Dermatology, China-Japan Friendship Hospital, National Center for Integrative Medicine","place":["Beijing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,4,20]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1111\/ijd.17801","article-title":"Eosinophilic annular erythema: Report of a case and successful management","volume":"64","author":"Castellanos-Molina","year":"2025","journal-title":"Int J Dermatol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1177\/2050313x231181024","article-title":"Vesiculobullous eosinophilic annular erythema: A case report","volume":"11","author":"Lachance","year":"2023","journal-title":"SAGE Open Med Case Rep"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdcr.2025.02.027","article-title":"Refractory eosinophilic annular erythema responsive to dupilumab: A case report and review of the literature","volume":"59","author":"Houpe","year":"2025","journal-title":"JAAD Case Rep"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1002\/ccr3.9009","article-title":"A rare case of eosinophilic annular erythema, an uncommon new entity of eosinophilic dermatosis","volume":"12","author":"Al-Zahawi","year":"2024","journal-title":"Clin Case Rep"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1111\/dth.14369","article-title":"Eosinophilic annular erythema: Report of four cases","volume":"33","author":"Fania","year":"2020","journal-title":"Dermatol Ther"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.5826\/dpc.1502a5143","article-title":"Eosinophilic annular erythema: Clinicopathologic analysis and therapeutic outcomes from a multicenter cohort","volume":"15","author":"Bettolini","year":"2025","journal-title":"Dermatol Pract Concept"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.5826\/dpc.1302a95","article-title":"Eosinophilic annular erythema due to certolizumab pegol therapy for rheumatoid arthritis post-COVID-19 vaccine","volume":"13","author":"Bassi","year":"2023","journal-title":"Dermatol Pract Concept"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.22657","article-title":"Eosinophilic annular erythema: A new entity of eosinophilic dermatosis","volume":"14","author":"Eljazouly","year":"2022","journal-title":"Cureus"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdcr.2021.07.034","article-title":"Eosinophilic annular erythema: A striking clinical presentation with potential systemic implications","volume":"16","author":"Gray","year":"2021","journal-title":"JAAD Case Rep"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.abd.2025.501194","article-title":"Successful treatment of refractory eosinophilic annular erythema with tofacitinib","volume":"100","author":"Niu","year":"2025","journal-title":"Bras Dermatol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1080\/09546634.2025.2490282","article-title":"Treatment of eosinophilic annular erythema with upadacitinib","volume":"36","author":"Xiang","year":"2025","journal-title":"J Dermatolog Treat"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1792217\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T05:24:42Z","timestamp":1776662682000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1792217\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,20]]},"references-count":11,"alternative-id":["10.3389\/fimmu.2026.1792217"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1792217","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,20]]},"article-number":"1792217"}}